Page 146 - Read Online

Page 18 of 18 Wallace et al. J Cancer Metastasis Treat 2019;5:9 I http://dx.doi.org/10.20517/2394-4722.2019.01

157. He M, Bian Z. Expression of hypoxia-induced semaphorin 7A correlates with the severity of inflammation and osteoclastogenesis in
experimentally induced periapical lesions. Arch Oral Biol 2017;75:114-9.
158. Garcia-Areas R, Libreros S, Amat S, Keating P, Carrio R, et al. Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in
macrophages of mammary tumor-bearing mice. Front Physiol 2014;5:17.
159. Ghanem RC, Han KY, Rojas J, Ozturk O, Kim DJ, et al. Semaphorin 7A promotes angiogenesis in an experimental corneal
neovascularization model. Curr Eye Res 2011;36:989-96.
160. Foskett AM, Ezekiel UR, Trzeciakowski JP, Zawieja DC, Muthuchamy M. Hypoxia and extracellular matrix proteins influence angiogenesis
and lymphangiogenesis in mouse embryoid bodies. Front Physiol 2011;2:103.
161. Swartz MA. Immunomodulatory roles of lymphatic vessels in cancer progression. Cancer Immunol Res 2014;2:701-7.
162. Hosono K, Isonaka R, Kawakami T, Narumiya S, Majima M. Signaling of prostaglandin E receptors, EP3 and EP4 facilitates wound healing
and lymphangiogenesis with enhanced recruitment of M2 macrophages in mice. PLoS One 2016;11:e0162532.
163. Zeng C, Chen L, Yang Z, Sun S. The close correlation between heparanase and COX-2 expression in lymphangiogenesis of cervical cancer.
Med Oncol 2014;31:314.
164. Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, et al. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of
lymphangiogenesis. Cancer Res 2007;67:10181-9.
165. Lala PK, Nandi P, Majumder M. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
Cancer Metastasis Rev 2018;37:369-84.
166. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes
on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2010;123:725-31.
167. Burke CA, Phillips R, Berger MF, Li C, Essex MN, et al. Children’s international polyposis (CHIP) study: a randomized, double-blind,
placebo-controlled study of celecoxib in children with familial adenomatous polyposis. Clin Exp Gastroenterol 2017;10:177-85.
168. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial
adenomatous polyposis. N Engl J Med 2000;342:1946-52.